A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
Recruiting · NCT07502560 · Registry updated 2026-05-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland | Alzheimer disease, DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, brain disorder, central nervous system disorder, cognitive disorder, dementia, herpes zoster, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, viral infectious disease | Recruiting | Phase 4 | 2026-05-12 | NCT07502560 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dr Arto Palmu | 1 |
| Finnish Vaccine Research; | 1 |
| GlaxoSmithKline | 294 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||